Abnormal Left Atrial Strain by CMR Is Associated With Left Heart Disease in Patients With Pulmonary Hypertension

Ben N Schmermund1,2, Andreas J Rieth1,2, Matthias Rademann1,2

  • 1Department of Cardiology (B.N.S., A.J.R., M.R., P.C.B., S.K., J.S.W., J.M.T., A.R., S.S., S.J.B.), Campus Kerckhoff of the Justus-Liebig-University Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany.

Circulation. Heart Failure
|September 1, 2025
PubMed

Insights

Left atrial strain (LA Es) impairment indicates left heart involvement in pulmonary hypertension (PH). LA Es is superior to left ventricular global longitudinal strain (GLS) for detecting exercise-induced left heart disease in PH patients.

Area of Science:

  • Cardiology
  • Pulmonary Hypertension
  • Cardiovascular Imaging

Background:

  • Pulmonary hypertension (PH) encompasses pre-capillary, isolated post-capillary (IpcPH), combined post- and pre-capillary (CpcPH), and exercise PH.
  • Left heart disease (LHD) can cause PH progression and is a common comorbidity.
  • Atrial functional impairment is a known consequence of cardio-pulmonary diseases.

Purpose of the Study:

  • To investigate atrial functional impairment across the spectrum of PH.
  • To assess the diagnostic performance of left atrial strain (LA Es) and left ventricular global longitudinal strain (GLS) in identifying LHD in PH patients.

Main Methods:

  • A monocentric registry included 209 patients undergoing right heart catheterization (RHC) and cardiovascular magnetic resonance (CMR) imaging.
  • Patients were classified into PH subgroups based on RHC findings.
  • CMR assessed ventricular and atrial volumes and deformation, including LA total strain (Es) and LV global longitudinal strain (GLS).

Main Results:

  • Median LA Es was significantly impaired in IpcPH (10.0%) and CpcPH (10.0%) compared to other PH types and normal hemodynamics.
  • LA Es and GLS demonstrated good performance in identifying resting LHD (PCWP ≥15mmHg).
  • LA Es was superior to GLS in identifying exercise-induced LHD (PCWP ≥25mmHg) (AUC 0.79 vs 0.70, p=0.039).

Conclusions:

  • Atrial functional impairment, specifically reduced LA Es, is indicative of LHD in PH patients.
  • LA Es is a more effective imaging biomarker than GLS for detecting exercise-induced LHD in PH.
  • LA strain analysis offers a promising, innovative approach for early detection of LHD in pulmonary hypertension.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55